Perrigo Company plc
Perrigo Company plc (PRGO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
prgo · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Perrigo Company plc (PRGO) measures how much investors pay for each dollar of the company's trailing earnings. PRGO's current PE ratio of N/A is calculated by dividing its stock price of $11.63 by its TTM earnings per share of -$13.10.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 13 fiscal years · Front-end computedMinQ1 · 25%25.9x
MedianQ3 · 75%207.5x
Max
At N/A, PRGO's current P/E is lower than in 0% of its annual fiscal year readings over the past 13 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Perrigo Company plcYou PRGO | $1.6B | N/A | — | -$13.10 |
 Alphatec Holdings, Inc. ATEC | $1.2B | N/A | — | -$0.96 |
 Bausch Health Companies Inc. BHC | $1.9B | 16.14x | +52.7% | $0.43 |
 Amicus Therapeutics, Inc. FOLD | $4.5B | N/A | — | -$0.09 |
 HUTCHMED (China) Limited HCM | $1.9B | 4.99x | -52.7% | $2.67 |
 Heartflow, Inc. Common Stock HTFL | $2.5B | N/A | — | -$0.32 |
 LivaNova PLC LIVN | $4.1B | N/A | — | -$4.45 |
Industry Average 2 peers with valid PE | — | 10.57x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-10.29 | — | |
2024-12-31 FY2024 | — | $-1.25 | — | |
2023-12-31 FY2023 | — | $-0.09 | — | |
2022-12-31 FY2022 | — | $-1.05 | — | |
2021-12-31 FY2021 | — | $-0.52 | — | |
2020-12-31 FY2020 | — | $-1.19 | — | |
2019-12-31 FY2019 | 48.09x | $1.07 | +18.0% | |
2018-12-31 FY2018 | 40.76x | $0.95 | -60.7% | |
2017-12-31 FY2017 | 103.70x | $0.84 | — | |
2016-12-31 FY2016 | — | $-28.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Perrigo Company plc (PRGO) measures how much investors pay for each dollar of the company's trailing earnings. PRGO's current PE ratio of N/A is calculated by dividing its stock price of $11.63 by its TTM earnings per share of -$13.10.
Frequently asked questions
PRGO pe ratio · 6 questionsPRGO's current PE ratio is N/A as of 2026-06-08, based on a stock price of $11.63 and TTM EPS of -$13.10. Data sourced from Financial Modeling Prep via PRGO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Perrigo Company plc SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08